Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nutriband Inc (NQ: NTRB ) 4.700 -0.010 (-0.21%) Streaming Delayed Price Updated: 10:50 AM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nutriband Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 Today 3:00 EDT Via ACCESSWIRE Proposed US Law Would Direct Opioid Settlement Cash to Opioid Crisis Management August 28, 2024 Via Investor Brand Network BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Execs to Participate in July 25 Investor Webinar July 19, 2024 Via Investor Brand Network Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 July 19, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology July 15, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property NTRB Stock Earnings: Nutriband Reported Results for Q1 2024 June 25, 2024 Nutriband just reported results for the first quarter of 2024. Via InvestorPlace Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors May 16, 2024 Via ACCESSWIRE NTRB Stock Earnings: Nutriband Reported Results for Q4 2023 May 03, 2024 Nutriband just reported results for the fourth quarter of 2023. Via InvestorPlace Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology July 15, 2024 Via ACCESSWIRE BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Shares Update on Its AVERSA(TM) Fentanyl Product Development Program June 20, 2024 Via Investor Brand Network Exposures Product Safety Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl June 20, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report June 03, 2024 Via Investor Brand Network Nutriband Inc. Announces $8.4M Private Placement April 19, 2024 Via ACCESSWIRE Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year June 03, 2024 Via ACCESSWIRE BioMedNewsBreaks — Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’ May 31, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session May 21, 2024 Via Investor Brand Network BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Names Seasoned Business Leader to Board of Directors May 16, 2024 Via Investor Brand Network Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 15, 2024 Via Benzinga BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Upcoming RedChip Small, Big Money(TM) Show May 10, 2024 Via Investor Brand Network Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV May 10, 2024 Via ACCESSWIRE Fentanyl Scourge: Nutriband Inc.’s (NASDAQ: NTRB) New Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval May 06, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise April 25, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Closes $8.4M Private Placement April 24, 2024 Via Investor Brand Network Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission April 24, 2024 Via ACCESSWIRE BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Enters Exclusive Supplier Agreement with Major Sports Brand Licensee April 23, 2024 Via Investor Brand Network Topics Supply Chain Exposures Supply Chain Nutriband Inc. (NASDAQ: NTRB) Advances Abuse Deterrent Tech Addressing Fentanyl Epidemic April 23, 2024 Via Investor Brand Network Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group April 23, 2024 Via ACCESSWIRE BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Enters Into Private Placement Agreements to Raise Funds for Development of AVERSA Fentanyl April 19, 2024 Via Investor Brand Network Exposures Product Safety Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’ April 10, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.